Spotting
 Timeline
 Travel Tip
 Trip
 Race
 Social
 Greeting
 Poll
 Img
 PNR
 Pic
 Blog
 News
 Conf TL
 RF Club
 Convention
 Monitor
 Topic
 Bookmarks
 Rating
 Correct
 Wrong
 Stamp
 PNR Ref
 PNR Req
 Blank PNRs
 HJ
 Vote
 Pred
 @
 FM Alert
 FM Approval
 Pvt
News Super Search
 ↓ 
×
Member:
Posting Date From:
Posting Date To:
Category:
Zone:
Language:
IR Press Release:

Search
  Go  

Kolkata Metro: The only Metro of IR. কলকাতা মেট্রো : তিলোত্তমার জীবন রেখা ।। - PPG

Full Site Search
  Full Site Search  
 
Sat Dec 5 15:19:52 IST
Home
Trains
ΣChains
Atlas
PNR
Forum
Topics
Gallery
News
FAQ
Trips/Spottings
Login
Advanced Search
<<prev entry    next entry>>
News Entry# 422494
Oct 23 (17:55) US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19 (www.ndtv.com)
*covid-19
0 Followers
813 views

News Entry# 422494  Blog Entry# 4756552   
  Past Edits
This is a new feature showing past edits to this News Post.
Remdesivir can only be given to patients in a hospital or equivalent setting (Representational)Washington: The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.Gilead said the drug, sold under the brand name Veklury, was the only specific treatment for Covid-19 approved so far under a more rigorous process.However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over.Other medications, like the steroid dexamethasone, are also being used in the fight against Covid-19.Gilead's shares on the New York Stock Exchange jumped four percent soon after the announcement."The FDA is committed to expediting the development and availability of Covid-19 treatments during this unprecedented public health emergency," said FDA Commissioner Stephen Hahn."Today's approval is supported by data...
more...
from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the Covid-19 pandemic."Europe and other countries such as Canada also have granted temporary approval for the use of remdesivir.Remdesivir, which is administered by an injection, was one of the first drugs to show relative promise in shortening the time to recovery in some coronavirus patients.But its efficacy in reducing the mortality rate is unproven.It can be administered to adults and children over the age of 12 who weigh more than 40 kilos (88 pounds) who require hospitalization for the treatment of Covid-19, the illness caused by the novel coronavirus.The drug can only be given to patients in a hospital or equivalent setting.Emergency approval has been granted for its use on pediatric patients under the age of 12 weighing at least 3.5 kilos.President Donald Trump, who tested positive for the coronavirus early in October, was treated with remdesivir at a military hospital outside Washington, among other drugs.Faster recovery timeThe drug was first developed to treat Ebola, a viral hemorrhagic fever.In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced it was dusting off remdesivir to investigate against SARS-CoV-2, the pathogen that causes Covid-19, because it had shown promise in animal testing against fellow coronaviruses SARS and MERS.Its study involving more than 1,000 people, the results of which were released in April, found that patients on the drug had a 31 percent faster time to recovery than those on a placebo.Since the medicine is complex to manufacture and is administered via injection, rather than a pill, there have been questions about whether supply could initially be limited.The United States bet early on remdesivir's success, rushing to preorder nearly all of Gilead's summer production.PromotedListen to the latest songs, only on JioSaavn.comGilead has set the price at $390 per vial in developed countries, or $2,340 for six vials used over the normal five-day course, though US private insurers will pay $520 per vial.(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.) Comments
Scroll to Top
Scroll to Bottom
Go to Mobile site
Important Note: This website NEVER solicits for Money or Donations. Please beware of anyone requesting/demanding money on behalf of IRI. Thanks.
Disclaimer: This website has NO affiliation with the Government-run site of Indian Railways. This site does NOT claim 100% accuracy of fast-changing Rail Information. YOU are responsible for independently confirming the validity of information through other sources.
India Rail Info Privacy Policy